![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 36, 28006-28016, September 8, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the
Department of Biochemistry, Duke University
Medical Center, Durham, North Carolina 27710 and the
§ Middle Atlantic Mass Spectrometry Laboratory, Department
of Pharmacology and Molecular Sciences, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205-2185
Received for publication, May 10, 2000, and in revised form, June 14, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Lipid A of Rhizobium etli CE3 differs
dramatically from that of other Gram-negative bacteria. Key features
include the presence of an unusual C28 acyl chain, a galacturonic acid
moiety at position 4', and an acylated aminogluconate unit in place of
the proximal glucosamine. In addition, R. etli lipid A is
reported to lack phosphate and acyloxyacyl residues. Most of these
remarkable structural claims are consistent with our recent enzymatic
studies. However, the proposed R. etli lipid A structure is
inconsistent with the ability of the precursor
(3-deoxy-D-manno-octulosonic
acid)2-4'-32P-lipid IVA to accept a
C28 chain in vitro (Brozek, K. A., Carlson, R. W., and Raetz, C. R. H. (1996) J. Biol.
Chem. 271, 32126-32136). To re-evaluate the structure, CE3 lipid
A was isolated by new chromatographic procedures. CE3 lipid A is now
resolved into six related components. Aminogluconate is present in D-1,
D-2, and E, whereas B and C contain the typical glucosamine
disaccharide seen in lipid A of most other bacteria. All the components
possess a peculiar acyloxyacyl moiety at position 2', which includes
the ester-linked C28 chain. As judged by mass spectrometry, the distal glucosamine units of A through E are the same, but the proximal units
are variable. As described in the accompanying article (Que, N. L. S., Ribeiro, A. A., and Raetz, C. R. H. (2000) J. Biol. Chem. 275, 28017-28027),
the discovery of component B suggests a plausible enzymatic pathway for
the biosynthesis of the aminogluconate residue found in species D-1,
D-2, and E of R. etli lipid A. We suggest that the unusual
lipid A species of R. etli might be essential during
symbiosis with leguminous host plants.
Gram-negative bacteria possess outer membranes consisting of a
lipid bilayer in which the outer leaflet is composed largely of
lipopolysaccharide (LPS)1
(1-7). The structure of LPS can be divided into three regions: 1) the
lipid A moiety, which serves as the hydrophobic anchor of LPS in the
outer membrane; 2) the core region, which consists of a nonrepeating
oligosaccharide; and 3) the immunogenic O-antigen, a
distinctly different but repeating oligosaccharide. Although the core
region confers upon the outer membrane the capacity to act as an
effective barrier to many antibiotics (8, 9), the lipid A moiety is
needed for cell viability (10-14). Furthermore, lipid A is the portion
of LPS that elicits many of the diverse pathophysiological responses
associated with severe Gram-negative infections of animals, such as
cytokine production, inflammation, and shock (1, 4, 6, 15-17).
The lipid A moiety found in typical Gram-negative bacteria, like
Escherichia coli, consists of a hexa-acylated disaccharide of glucosamine that is Under certain growth conditions, both the 1- and 4'- phosphates of
E. coli and S. typhimurium lipid A may be further
modified with polar moieties, such as
4-amino-4-deoxy-L-arabinose or phosphoethanolamine (24-29). The presence of these additional substituents is implicated in conferring polymyxin resistance and may be required for the intracellular survival of S. typhimurium (30-32). These
observations (22, 23, 30-32) demonstrate that subtle changes in the
structure of lipid A may have profound effects on pathogenesis.
The most remarkable lipid A structure reported to date is that of
Rhizobium etli CE3 (see Fig. 1), a bacterial endosymbiont that differentiates to form nitrogen-fixing bacteroids in the root
cells of bean plants (33, 34). R. etli lipid A not only is
missing both phosphate groups, but also is reported to lack an
acyloxyacyl moiety (see Fig. 1) (33, 34). The 4' position (see Fig. 1)
is substituted with a galacturonic acid residue, whereas the proximal
glucosamine unit is replaced with an aminogluconate moiety (33, 34). A
long fatty acid (27-hydroxyoctacosanoic acid), characteristic of the
Rhizobiaceae (35), is proposed to be attached to the aminogluconate
residue by an ester linkage at C-5 (see Fig.
1) (33, 34). The 27-OH group is further
acylated with a
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, 1'-6 linked and is phosphorylated at positions 1 and 4' (see Fig. 1) (1, 4, 6, 17). Most variations on this
structural theme are relatively modest. For instance, the fatty acyl
chain lengths and/or the number of secondary acyl chains may differ
from strain to strain (1, 4, 17). However, five acyl chains (including
one acyloxyacyl moiety) are usually present (1, 4, 17). In bacteria
that normally contain two secondary acyl chains, the absence of one of
these moieties, as in lipid A of E. coli or Salmonella
typhimurium msbB mutants (18-21), does not inhibit growth,
but the mutant bacteria lose their capacity to induce robust cytokine
synthesis in animals (22, 23). In fact, S. typhimurium msbB
mutants are unable to kill mice, despite rapid proliferation in the
infected animals (22, 23).
-hydroxybutyrate residue (33, 34). Given that the O-antigen region of R. etli and
Rhizobium leguminosarum LPS is necessary for normal
maturation of nitrogen-fixing bacteroids (36-38), the unusual lipid A
of R. etli might somehow also be required for infection of
plant cells and/or symbiosis.

View larger version (18K):
[in a new window]
Fig. 1.
Structure of E. coli lipid A
compared with the previously published structure of R. etli
CE3 lipid A. The backbone carbons are numbered on the
assumption that the proximal aminogluconate moiety of R. etli lipid A is derived from a lipid A precursor common to both
systems, such as Kdo2-lipid IVA, in which the
proximal unit is not an aminogluconate moiety but glucosamine. The
molecular weight of E. coli lipid A is 1798.8, whereas that
of the previously proposed (33, 34) R. etli CE3 lipid A
species shown above is predicted to be 2313.31.
Enzymatic studies from our laboratory are largely consistent with the
proposed structure of R. etli lipid A (39-43). R. etli initiates the biosynthesis of lipid A with
UDP-N-acetylglucosamine and hydroxyacyl-ACP (see Fig. 2), as
does E. coli (39). After formation of the key intermediate
Kdo2-lipid IVA (39), R. etli then
employs unique enzymes, such as its 4'- and 1-phosphatases (40, 41), to
generate its own unusual lipid A precursors (see Fig. 2). A special
acyl carrier protein and a unique membrane enzyme for transferring
27-hydroxyoctacosanoic acid to Kdo2-lipid IVA
have also recently been discovered (see Fig. 2) (42). Interestingly, the latter system is not consistent with the proposed R. etli lipid A structure (see Fig. 1), because the 5 position of the proximal unit is not available to accept the 27-hydroxyoctacosanoate residue in the substrate Kdo2-lipid IVA (see
Fig. 2) (42). The C28 acyltransferase of R. etli furthermore
resembles the HtrB acyltransferase of E. coli, which
generates the acyloxyacyl residue at position 2' (Figs.
1 and 2),
in its strict dependence upon the presence of the Kdo disaccharide in
the substrate (42). The issue of whether or not R. etli
lipid A might contain an acyloxyacyl unit involving the C28 chain (33,
42) therefore needed to be reinvestigated.
|
We now demonstrate that lipid A of R. etli LPS is in fact
much more complex than previously reported (33, 34). Several new
chromatographic methods for the purification and separation of R. etli lipid A were developed (44), permitting the identification of
at least six distinct but related lipid A species. In contrast to
previous studies (33, 34), we obtained these R. etli lipid A
fractions without resorting to strong acid or base hydrolysis, thereby
greatly facilitating the analysis of the intact species by MALDI/TOF
mass spectrometry, NMR spectroscopy, and GC/MS. With this information,
we were able to deduce logical structural skeletons for these
molecules. All six purified components possess the same distal ends but
are intriguingly heterogeneous in their proximal units. Some of the
purified species contain the novel aminogluconate residue (33, 34), but
others consist of a more conventional glucosamine disaccharide
backbone. Evidence is presented for a single acyloxyacyl group in the
distal unit of each of the six components. The secondary fatty acyl
chain of this acyloxyacyl residue is the 27-hydroxyoctacosanoate
moiety. Our revised structures are consistent with previous enzymatic
studies of Kdo2-lipid IVA acylation in R. etli extracts (42). The accompanying article (73) presents an in
depth NMR analysis of the purified substances.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials-- Glass backed 0.25-mm Silica Gel 60 thin layer chromatography plates were obtained from Merck. Chloroform, ammonium acetate and sodium acetate were purchased from EM Science, whereas pyridine, methanol, and 88% formic acid were from Mallinckrodt. The 2,5-dihydroxybenzoic acid was purchased from Sigma.
Bacterial Cells and Growth Conditions-- Cells of R. etli CE3 were grown in shaking culture at 30 °C in TY broth (5 g of Bacto-peptone and 3 g of yeast extract), supplemented with 10 mM CaCl2, 20 µg/ml nalidixic acid, and 200 µg/ml streptomycin sulfate (39, 40).
Cell Preparation and Recovery of Crude Lipid A--
Five liters
of fresh TY broth (1000 ml/4-liter Erlenmeyer flask), supplemented with
10 mM CaCl2, 20 µg/ml nalidixic acid, and 200 µg/ml streptomycin sulfate, were inoculated with 25 ml of a fresh
culture of R. etli CE3 (A550
1.2). The flasks were shaken (225 rpm) at 30 °C overnight until the
A550 reached 1.2. The cells were harvested by
centrifugation at 5000 × g for 15 min at 4 °C. The
cells were resuspended, washed once with 900 ml of chilled 50 mM HEPES buffer, pH 7.5, and centrifuged once more. The
washed cell pellets were frozen at
80 °C.
Thawed cell pellets were resuspended in 320 ml of phosphate-buffered saline, pH 7.4. To extract the glycerophospholipids, the cell suspension was converted to a single phase Bligh-Dyer mixture by the addition of 400 ml of chloroform and 800 ml of methanol. After incubation for 1 h at room temperature with occasional stirring, the mixture was centrifuged at 7520 × g, for 15 min. The insoluble material was recovered and washed once with 380 ml of a fresh, single phase Bligh-Dyer mixture, consisting of CHCl3/MeOH/H2O (1:2:0.8 v/v/v). The insoluble material was again recovered by centrifugation, and the supernatant was discarded. The washed pellet, which contains the LPS with its covalently bound lipid A moiety, was then suspended in a 120-ml portion of 12.5 mM sodium acetate, pH 4.5, containing 1% SDS. Dispersion was facilitated by a brief sonic irradiation in a Virsonic cell disrupter. The volume was then adjusted to 360 ml with 12.5 mM sodium acetate, pH 4.5, containing 1% SDS. At this point, the pH was readjusted to 4.5 by careful dropwise addition of glacial acetic acid. The suspension was divided between two 500-ml glass bottles covered with loose caps. The glycosidic bond between the inner Kdo of the core and the lipid A moiety was cleaved by heating the suspension to 100 °C in a boiling water bath for 30 min (29, 45-49). After cooling, the suspension was divided into ten 36-ml aliquots, each of which was placed into a 150-ml Corex glass tube. The contents of each tube were converted to a two-phase Bligh-Dyer mixture (50) by addition of 40 ml of chloroform and 40 ml of methanol. The phases were mixed thoroughly and were separated by centrifugation at 7520 × g for 15 min at 25 °C. The lower phases, containing the released lipid A, were combined and passed through a funnel plugged with glass wool to remove insoluble cell debris. A second extraction of the remaining upper phases was done by adding to each tube 40 ml of a pre-equilibrated lower phase, which was obtained from a fresh two-phase Bligh-Dyer mixture, consisting of CHCl3/MeOH/H2O (2:2:1.8 v/v/v). These mixtures were again centrifuged to separate the phases (as above), and the lower phases from the second extraction were filtered and pooled with the lower phases from the first extraction.
After drying the pooled lower phases by rotary evaporation in a 500-ml
round bottom flask at room temperature, another two-phase partitioning
was carried out to reduce the amount of SDS in the sample. The dried
material was redissolved in 240 ml of chloroform/methanol (1:1 v/v) and
was then equally divided between six 150-ml Corex glass bottles. The
round bottom flask was rinsed with a second 240-ml solution of
chloroform/methanol (1:1 v/v), and the contents were equally
distributed between the six Corex bottles. The portion in each Corex
bottle was then converted to a two-phase Bligh-Dyer system by adding 36 ml of water. The phases were mixed thoroughly and separated by
centrifugation at 7520 × g for 15 min at room temperature. The lower phases were recovered and filtered as above. The
filtrate was collected in a 500-ml round bottom flask, dried by rotary
evaporation, sealed, and stored at
20 °C. About 160 mg of crude
lipid A (contaminated with SDS and residual glycerophospholipids) was obtained.
Resolution of Multiple R. etli Lipid A Species by Ion Exchange
Chromatography--
The first step in the purification of the lipid A
species of R. etli CE3 made use of anion exchange
(DEAE-cellulose) chromatography, as described previously for E. coli lipid A (25, 29, 48, 51). A 60-ml DEAE-cellulose (Whatman
DE52) column (2.5 × 13 cm) in the acetate form (25, 51) was
equilibrated with the solvent CHCl3/MeOH/H2O
(2:3:1 v/v/v). The entire crude lipid A sample, prepared as described
above, was dissolved in 100 ml of CHCl3/MeOH/H2O (2:3:1 v/v/v) and loaded onto
the column by gravity flow. The same solvent mixture (10 ml) was used
to rinse the flask, and the additional material was also loaded onto
the column. The run-through was collected as a single fraction. Next,
the column was washed with 80 ml of
CHCl3/MeOH/H2O (2:3:1 v/v/v), also collected as
a single fraction. The various lipid A components were then eluted by
increasing the salt concentration of the aqueous portion stepwise in
the following manner: 1) 240 ml of CHCl3/MeOH/30
mM NH4Ac (2:3:1 v/v/v); 2) 180 ml of
CHCl3/MeOH/60 mM NH4Ac (2:3:1 v/v/v); 3) 180 ml of CHCl3/MeOH/120 mM
NH4Ac (2:3:1 v/v/v); and 4) 180 ml of
CHCl3/MeOH/500 mM NH4Ac (2:3:1
v/v/v). Fractions of 14 ml were collected, and 20-µl portions of each
fraction were spotted onto 10 × 20-cm Silica Gel 60 TLC plates to
monitor the lipid A elution profile. The plates were then developed in
the solvent CHCl3/MeOH/H2O/NH4OH
(40:25:4:2 v/v/v/v). Spots were visualized by spraying the chromatogram
with
ethanol/p-anisaldehyde/H2SO4/HOAc (89:2.5:4:1 v/v/v/v) or with 10% sulfuric acid in ethanol, followed by
charring on a hot plate. Two sets of lipid A-related components were
resolved. Three components (designated A, B, and C) eluted with
CHCl3/MeOH/30 mM NH4Ac (2:3:1
v/v/v). The second set of compounds (D-1, D-2, and E) emerged with
CHCl3/MeOH/120 mM NH4Ac (2:3:1 v/v/v). Fractions containing these components were converted to two-phase Bligh-Dyer mixtures by addition of the appropriate
amounts of chloroform and water. After mixing, the phases were
separated by centrifugation at 7520 × g at room
temperature for 15 min. The lower phases from the fractions of the 30 mM NH4Ac elution step (which contain A, B and
C) were pooled and dried by rotary evaporation. Fractions from
the 120 mM NH4Ac elution step (components D-1,
D-2, and E) were processed in the same manner. After drying, all
the samples were stored at
20 °C (~20 mg of combined weight).
Purification and Separation of A, B, and C-- Component C was separated from A and B by chromatography on a Bio-Sil column. The dried mixture of A, B, and C from the DEAE-cellulose step was dissolved in 9.5 ml of CHCl3:MeOH (95:5 v/v) and was loaded onto an 18-ml acid-washed Bio-Sil column (8.5 × 2 cm) that had been pre-equilibrated in 250 ml of CHCl3:MeOH (95:5 v/v). The column was then washed stepwise with solvents of increasing polarity, and fractions were collected as follows: 1) 160 ml of CHCl3:MeOH (95:5 v/v) in 14-ml fractions; 2) 80 ml of CHCl3:MeOH (90:10 v/v) in 8-ml fractions; 3) 240 ml of CHCl3:MeOH (85:15 v/v) in 4-ml fractions; and 4) 90 ml of CHCl3:MeOH (2:1 v/v) in 4-ml fractions. To detect the lipid A, 10-20-µl portions of each fraction were spotted onto silica gel TLC plates and analyzed by chromatography and charring, as described above for the DEAE-cellulose step. Components A and B eluted with CHCl3/MeOH (95:5 v/v and 90:10 v/v) but were not resolved from each other. Component C started to elute only in the CHCl3/MeOH (85:15 v/v) step. Fractions containing species A and B were pooled and dried by rotary evaporation. The same was done for the fractions containing C.
To resolve components A and B from each other, preparative thin layer
chromatography was employed (29). Fractions from the silica column
containing A and B were redissolved in ~0.5 ml of CHCl3/MeOH (4:1 v/v), and a 0.5-mg sample was applied in a
line to a 20 × 20-cm Silica Gel 60 analytical TLC plate (0.25-mm
thickness). A solvent composed of chloroform/pyridine/88% formic
acid/MeOH/H2O (60:35:10:5:2 v/v/v/v/v) was used for
chromatography. Care was taken to load just enough of the sample per
plate (0.2-0.5 mg) so that after the chromatogram was developed and
dried, the locations of the discrete lipid A bands on the plate were
transiently visible as white zones when viewed on a light box. After
developing, the bands were marked with a pencil, and the plates were
allowed to dry completely at room temperature for 30 min before the
marked zones were scraped off with a clean razor blade. Each compound was then extracted from the silica chips with 3.8 ml of an acidic single-phase Bligh-Dyer mixture, consisting of
CHCl3/MeOH/0.1 M HCl (1:2:0.8 v/v/v). After
mixing, the suspension was left at room temperature for 5 min. The
suspension was then converted into a two-phase Bligh-Dyer system by
adding 2 ml of CHCl3, 1 ml of methanol, and 1.9 ml of
water. The system was mixed, and the two phases were separated by
centrifugation for 8 min at room temperature in a clinical centrifuge.
The lower phase was recovered, passed through a Pasteur pipette fitted
with a small glass wool plug, and collected in a 16 × 125-mm glass tube. The remaining upper phase was re-extracted with 3 ml
of a pre-equilibrated lower phase derived from a fresh neutral Bligh
and Dyer mixture, consisting of CHCl3/MeOH/H2O
(2:2:1.8 v/v/v). The lower phases from the two extractions were pooled
and dried down under a stream of N2. Finally, the
individual TLC-purified samples were passed through another 1-ml
DEAE-cellulose column (29), equilibrated, and eluted on a scale
proportionally smaller than that described above, to remove residual
silica chips and other possible contaminants, such as metal ions. The
purified components were stored dry at
20 °C.
Purification and Separation of D-1, D-2, and E--
Components
D-1, D-2, and E, which elute together during the anion exchange step,
were resolved by preparative thin layer chromatography using the
solvent chloroform/pyridine/88% formic acid/MeOH/H2O (60:35:10:5:2 v/v/v/v/v). Chromatography and elution from the silica
chips was carried out as described above for A and B. Passage over a
final 1-ml DEAE-cellulose column was also carried out, as described
above for A and B, and all the purified lipid A samples were stored dry
at
20 °C.
Mass Spectrometry-- Matrix-assisted laser desorption ionization/time of flight (MALDI/TOF) mass spectra were acquired on a Kompact MALDI 4 from Kratos Analytical (Manchester, UK) equipped with a nitrogen laser (337 nm), 20 kV extraction voltage, and time delayed extraction. The samples were prepared for MALDI/TOF analysis by depositing 0.3 µl of the sample dissolved in chloroform/methanol (4:1 v/v), followed by 0.3 µl of a saturated solution of 2,5-dihydroxybenzoic acid in 50% acetonitrile as the matrix. The sample was left to dry at room temperature. Spectra were acquired in both the positive and negative ion linear modes. Each spectrum was the average of 50 laser shots.
GC/MS Analysis of the Purified Components A, B, and D-1-- The purified lipid A components were hydrolyzed in acidic methanol, N-acetylated, and then converted to trimethylsilyl ethers, without reduction of the carboxyl groups of the acidic sugars or fatty acids present in the samples (52). In separate 1-ml Reacti-vials (Pierce) equipped with Teflon-lined screw caps, 0.3-0.5 mg of A, B, and D-1 were thoroughly dried on a lyophilizer. Samples were hydrolyzed by adding to each vial 250 µl of 1 M HCl in methanol (prepared with an Altech kit) and placing the capped samples in a heat block set at 80 °C for 15 h. The reaction mixtures were cooled, and a drop of t-butanol was added to each vial. After mixing, the solvents were removed at room temperature under a stream of nitrogen. Next, N-acetylation of the amino sugars was achieved by adding 200 µl of anhydrous methanol, 40 µl of pyridine, and 40 µl of acetic anhydride to each sample. These solutions were mixed with the aid of a vortex and allowed to incubate overnight at room temperature. The samples were evaporated under a stream of nitrogen and again dried on a vacuum pump. Finally, silylation of free OH groups was achieved by adding 200 µl of Tri-Sil reagent (Pierce) to the dried samples. After mixing on a vortex for 30 s, silylation was allowed to proceed at room temperature for an hour. The volatile components were evaporated under a gentle stream of nitrogen, and the samples were redissolved in 100 µl of hexane and transferred to new vials. A mixture of standards, consisting of equimolar glucosamine, galacturonic acid, and 2-aminogluconate (Sigma), was processed in parallel.
GC/MS was done with a Finnigan MAT 95 coupled to a Hewlett-Packard
Series II model 5890 gas chromatograph. The column used was a 60 m
DB-5 (0.25-micron film; 0.25-mm internal diameter) from J & W
Scientific with helium as the carrier gas. GC/MS analysis was executed
with on-column injection and an ion source temperature of 200 °C.
The temperature program consisted of an initial temperature of 80 °C
for 2 min, followed by an increase to 300 °C at a rate of
4 °C/min. The column was then usually held at 300 °C for 30 min.
However, it was held at 300 °C for 60 min for detecting the C28
fatty acid species. Chemical ionization mass spectrometry was performed
with ammonia as the reactant gas. Electron impact mass spectra were
recorded at 70 eV.
| |
RESULTS |
|---|
|
|
|---|
Microheterogeneity of R. etli Lipid A Released from Cells by Hydrolysis at pH 4.5-- In previous studies, R. etli CE3 lipid A was obtained by hydrolysis of crude R. etli LPS isolated by hot phenol water extraction of cells in 1% acetic acid at 100 °C (33, 34). The resulting lipid A preparations were then analyzed without further purification (33, 34). In contrast, we isolated lipid A directly from whole cells that are first depleted of their glycerophospholipids by extraction with chloroform/methanol/water at room temperature (10). In our procedure, the lipid A is then released from the LPS that remains associated with the extracted cell pellet by mild hydrolysis in sodium acetate buffer at pH 4.5 (29, 45, 48). Under these conditions, the labile glycosidic linkage between the Kdo and lipid A is cleaved selectively without damage to ester substituents (29, 45-48).
When analyzed by thin layer chromatography on silica plates followed by
charring, the lipid A components released from cells by pH 4.5 hydrolysis were surprisingly complex. At least five bands were resolved
(Fig. 3). Unlike E. coli lipid
A, R. etli lipid A could not be visualized on the TLC plates
with reagents that detect phosphate (not shown). A lipid A sample
prepared from R. etli LPS by the previously described
methods (kindly provided by Dr. R. Carlson) generated a similar pattern
of complex bands (not shown).
|
Chromatography of R. etli Lipid A Components on DEAE-Cellulose-- The lipid A mixture released from cells (Fig. 3) was subjected to anion exchange chromatography on a DEAE-cellulose column prepared in CHCl3/MeOH/H2O (2:3:1 v/v/v). Given the lack of phosphate residues (33), R. etli lipid A displays a much weaker affinity for DEAE-cellulose than does E. coli lipid A. The latter slowly elutes with CHCl3/MeOH/240 mM NH4Ac (2:3:1 v/v/v) (29, 48), whereas the R. etli lipid A species elute in two distinct groups at much lower salt concentrations. Components A, B and C emerge with CHCl3/MeOH/30 mM NH4Ac (2:3:1 v/v). D-1, D-2, and E elute with CHCl3/MeOH/60-120 mM NH4Ac. These findings suggest that A, B, and C each contain a single negatively charged group, whereas D-1, D-2, and E may each contain two negative charges.
Component C was resolved from A and B on a Bio-Sil column. Thin layer
chromatography on the 0.5-2-mg scale proved to be the most practical
way to obtain pure A, B, D-1, D-2, and E. As a final purification step,
prior to structural characterization, all components purified by TLC
were subjected to a second DEAE-cellulose mini-column (see
"Experimental Procedures") to eliminate residual silica particles,
minor degradation products, and metal ions. A thin layer analysis of
the purified substances is shown in Fig. 4A. An alternative solvent
system was used in the experiment shown in Fig. 4B to
separate components D-1, D-2, and E.
|
Negative Ion MALDI/TOF Mass Spectrometry of B, C, D-1, D-2, and
E--
The negative ion MALDI/TOF mass spectra of B, C, D-1, D-2, and
E are shown in Fig. 5. The four most
prominent peaks observed for each of these substances are interpreted
as a set of molecular ions [M
H]
, arising from
related molecular species, differing either in fatty acyl chain length
(differences of 28 atomic mass units) and/or the presence of a
-hydroxybutyryl moiety (differences of 86 atomic mass units). For
instance, in the case of B, the peak at m/z
1985.8 is interpreted as [M
H]
of a molecular
species containing a fatty acid that is two methylene units longer than
the species giving rise to the peak at m/z
1957.7. The peak at m/z 1899.6 might be derived
from a compound with the same fatty acid chain lengths as the species
seen at m/z 1985.8 but lacking the
-hydroxybutyryl substituent (86 atomic mass units). This
interpretation is entirely consistent with previous studies of the
composition of R. etli lipid A, which demonstrated some fatty acid chain length heterogeneity, and the presence of an ester-linked
-hydroxybutyryl substituent attached to the
27-hydroxyoctacosanoate moiety (33, 34). Given that significant
fragmentation is not expected during MALDI/TOF mass spectrometry in the
negative ion mode, it appears that there is genuine heterogeneity with
regard to the presence or absence of the
-hydroxybutyryl
substituent.
|
The four predominant peaks, attributed to [M
H]
, in component C are each ~227 atomic mass units
smaller than the four major peaks seen in B (Fig. 5), strongly
suggesting the absence of a one
-hydroxymyristoyl residue in C
versus B. The small variations (±0.5 atomic mass units) in
the mass differences for each of the corresponding peaks in B
versus C are consistent with the precision of MALDI/TOF mass
spectrometry. Similarly, the four peaks in E are ~227 atomic mass
units smaller than their counterparts in D-1 or D-2, demonstrating that
E is related to D-1/D-2 in the same way that C is to B.
As shown in Fig. 5, the four major peaks in D-1 and D-2 are approximately 16 atomic mass units larger than the corresponding peaks in component B, suggesting the presence of an additional oxygen atom in D-1 and D-2 versus B. The negative ion MALDI/TOF mass spectrum of D-1 is the same as that of D-2 (Fig. 5) within experimental error. Similarly, the four major species in E are 16-17 atomic mass units larger than the ones in C (Fig. 5). Taken together with the GC/MS data discussed below, we propose that B and C each contain two glucosamine residues, whereas D-1, D-2, and E each contain one glucosamine and one aminogluconate moiety (thereby accounting for the extra oxygen atom in D-1 and D-2 versus B).
Positive Ion MALDI/TOF Mass Spectrometry--
Although
negative ion MALDI/TOF mass spectrometry readily reveals the sizes of
the parent ions [M
H]
, the positive ion mode
may provide information about the sizes of the proximal and distal
units of the lipid A disaccharide. The positive ion MALDI/TOF spectra
of components B, C, D-1, D-2, and E are shown in Fig.
6.
|
The positive ion spectrum of B (Fig. 6) displays four prominent peaks
at m/z 2008.5, 1980.2, 1922.1, and 1894.4, each
interpreted as [M + Na]+. These values are consistent
with the peaks, attributed to [M
H]
, at
m/z 1985.8, 1957.7, 1899.6, and 1871.7, respectively, seen for B (Fig. 5). Similarly, the molecular ions,
interpreted as [M + Na]+, of C, D-1, D-2, and E in the
positive ion spectra (Fig. 6) are each 23-24 atomic mass units larger
than their corresponding [M
H]
peaks (Fig. 5).
With the proper ionization energy in positive ion MALDI/TOF mass
spectrometry, it is possible to generate sufficient amounts of the
B1+ oxonium ion (53), which is
formed during fragmentation of the glycosidic linkage, to determine the
mass of the distal lipid A unit. The same
B1+ ions within experimental error
(1299.6-1300.3 atomic mass units) are observed for B, C, D-1, D-2, and
E (Fig. 6), indicating that the distal units are very likely the same
in each of these substances. As in the negative ion mode (Fig. 5), the
entire spectrum of D-1 is virtually identical to that of D-2. The
heterogeneity of R. etli lipid A, including the variability
of the acyl chains and the presence or absence of aminogluconate, is
mainly a property of the proximal unit. However, partial substitution
with
-hydroxybutyrate (86 atomic mass units) appears to be a
distinct feature of the distal unit, because a smaller
B1+ ion peak is observed near
m/z 1213.4 in most of the samples (Fig. 6). In
this interpretation, the peak seen at m/z 1299.9 in component B is derived by glycosidic bond cleavage of either of the
two molecular species that give rise to the sodium adduct ions at m/z 2008.5 and 1980.2 (Fig. 6). The peak at
m/z 1213.4 is derived from the two species that
generate the sodium adducts seen at m/z 1922.1 and 1894.4 (Fig. 6).
Components D-1 and D-2 May Be Interconverted-- Components D-1 and D-2 are identical in all respects when analyzed by MALDI/TOF mass spectrometry. However, when they are incubated separately at room temperature overnight in 50 mM HEPES at pH 7.5, interconversion is observed, as judged by thin layer chromatography using the methods described Fig. 4B (data not shown). The interconversion of D-1 and D-2 most likely is due to the migration of the ester-linked acyl group between the 3- and/or the 4 and 5 positions of the proximal unit. Similar isomerization reactions have been extensively documented in the case of mono-acylated lipid A precursors (54) and with certain glycerol based lipids (55).
MALDI/TOF Mass Spectrometry of Mild Base-hydrolyzed Components C
and B--
When fractions containing A, B, and C from the
DEAE-cellulose column were subjected to preparative TLC using the
solvent CHCl3/MeOH/H2O/NH4OH (40:25:4:2 v/v/v/v) rather than the preferred pyridine-containing solvent (see "Experimental Procedures"), partial decomposition was
observed. Specifically, after the desired bands were extracted from the
silica chips with a neutral single phase Bligh-Dyersystem, selective
3'-O-deacylation of all the samples was noted. However, the
acyloxyacyl groupat position 2' remained intact, as judged by mass
spectrometry. Consequently, the B1+ ions
generated during positive ion MALDI/TOF analysis of lipid A samples
hydrolyzed in this fashion served to identify the fatty acids that
comprise the 2' acyloxyacyl moiety and the 3' acyl substituent of the distal sugar unit.
|
As shown in Figs. 7 and 8, C and B each
lose a single acyl chain upon exposure to the ammonia-containing TLC
system, as indicated by the molecular ions [M + Na]+ at
m/z 1556.2 for C and at m/z
1784.6 for B in the positive ion MALDI/TOF spectra. These signals
differ from those of intact C or B by ~226
atomic mass units (Fig. 6), indicative of the loss of a
-hydroxymyristoyl group. These assignments are confirmed in the
negative ion mode spectra (Figs. 7 and 8). Figs. 7 and 8 also show that
deacylation occurred on the distal glucosamine units of C and B, given
that the B1+ ions of decomposed C and B
(m/z 1073.2 and 1073.9, respectively) are 226 atomic mass units smaller than the B1+
ions of intact C and B (Fig. 6). The sizes of the
B1+ fragment ions therefore indicate
that the C28 chain is still present in the distal units of deacylated C
and B and that it must comprise part of an acyloxyacyl moiety at N-2',
because the C28 chain itself is ester-linked (33).
|
GC/MS Analysis of Components B and D-1--
A GC trace of the
trimethylsilyl ethers of the N-acetylated methylglycosides
and the trimethylsilyl ethers of the fatty acid methyl esters obtained
from purified B and D-1 are shown in Fig. 9. Peak assignments were based on the
patterns observed with standards that were prepared and run in
parallel. In addition, the masses for each of the peaks derived from B
and D-1, observed in the GC traces, were determined by on-line electron
impact and chemical ionization mass spectrometry. These spectra were
compared with those of the standards, further validating the
assignments. The sugar and fatty acid constituents that comprise the
individual purified R. etli lipid A components are
unambiguously revealed by this procedure (Fig. 9).
|
Interestingly, six fatty acids were detected: 3-OH C14:0, 3-OH C16:0, 3-OH C18:0, two isomers of 3-OH C15:0, and 27-OH C28:0. The latter emerges after 50 min and is not shown in Fig. 9. These results are consistent with the heterogeneity in the fatty acyl chain composition of the proximal unit of B (Figs. 5 and 6). The fatty acid composition of D-1 is similar to that of B (Fig. 9). What is important, however, is that the sugars present in B consist only of galacturonic acid and glucosamine, whereas D-1 clearly contains an additional sugar not present in B. The extra peak, eluting at 28 min, 50 s (Fig. 9), isattributed to 2-aminogluconate, based on the standards. These results unequivocally demonstrate the presence of 2-aminogluconate in D-1 but not in B, and strongly suggest that the sugar backbone of B is composed of two glucosamine units. Overall, these findings are completely consistent with the MALDI/TOF mass spectrometry of B and D-1/D-2 (Figs. 5 and 6). It must be emphasized that unambiguous interpretation of these results was made possible only because of our ability to separate the individual components of R. etli lipid A. GC/MS analysis of component A gave results that were qualitatively similar to those obtained for B (not shown).
Proposed Structures for B, C, D-1, and E--
As shown in Fig.
10, we can deduce logical structures
for the major molecular species present in B, C, D-1, and E by
combining the results of the mass spectrometry of the isolated
substances (Figs. 5-8) with the GC/MS analyses of the fatty acid and
sugar compositions of components B and D-1 (Fig. 9). In contrast to the
previously published structure (Fig. 1) (33, 34), we suggest that the
27-hydroxyoctacosanoate chain is attached to the distal unit as part of
an acyloxyacyl moiety. The predicted size of the B1+ ion (1299.8 atomic mass units; Fig.
10), which is within experimental error of the observed values (Fig.
6), together with the presence of the
-hydroxybutyryl group on the
distal unit strongly support our idea. A complete comparison of the
predicted molecular weights and the observed peaks for the largest of
the major species present in B, C, D-1/D-2, and E is shown in Table
I. All of the observed peaks are within
one mass units of the values predicted by the structural formulas shown
in Fig. 10. In contrast, the molecular weight of the published R. etli lipid A structure (33, 34) is predicted to be 2313.31 (Fig.
1). Ions corresponding to the latter value are not observed
(Figs. 5 and 6). Lastly, the more conventional nonphosphorylated
glucosamine disaccharide backbone that we have found in components B
and C was not originally proposed for R. etli lipid A (33,
34).
|
|
Mass Spectrometry of Component A--
The MALDI/TOF mass spectra
of component A in the negative ion and positive ion modes are shown in
Fig. 11. A major peak at m/z 1739.1, attributed to [M
H]
, is seen in the negative ion spectrum, and a second
major species at m/z 1710.8 is attributed to
fatty acyl chain length heterogeneity. Smaller amounts of molecular
species lacking the
-hydroxybutyrate substituent are seen at
m/z 1653.5 and 1625.2 (Fig. 11), similar to what
is observed with B, C, D-1, D-2 and E (Fig. 5). In the positive ion
MALDI/TOF spectrum (Fig. 11), the most intense peaks obtained are the
four molecular ions attributed to [M + Na]+ at
m/z 1763.0, 1734.9, 1676.7, and 1648.6, consistent with the negative ion MALDI/TOF results. Importantly, the
signal arising from the B1+ ion of A is
seen at m/z 1300.2, again indicating that the
distal unit of A is the same as that of the other R. etli
lipid A components (Fig. 6). When compared with B or D-1, the molecular
masses observed in the spectrum of A suggest the possible elimination
of
-hydroxymyristic acid and an additional water molecule (244 + 18 = 262 atomic mass units) from the proximal unit of D-1
(molecular weight of 2002.8), as opposed to deacylation. A plausible
scenario is that the additional water molecule arises by lactonization
of the aminogluconate residue. However, a reasonable structure cannot
yet be proposed based solely upon mass spectrometry. Interestingly,
component A appears to be generated specifically from D-1 by pH 4.5 hydrolysis at 100 °C (data not shown), suggesting that A is actually
not made by living cells. The fact that A is not formed when B is
subjected to the same hydrolytic conditions (data not shown) lends
further credence to A being derived from D-1.
|
| |
DISCUSSION |
|---|
|
|
|---|
Following infection of plant root hair cells, bacterial endosymbionts, such as R. etli, Rhizobium meliloti, and R. leguminosarum undergo complex developmental changes to form nitrogen-fixing bacteroids (56-59). A bacterial outer membrane component likely to be involved in establishing this symbiotic relationship is LPS. The presence of an O-antigen polymer on LPS is required for proper nodule development by R. etli and R. leguminosarum (36, 37, 60), and O-antigen undergoes some structural modifications during nodule formation, as judged by immunological studies (61, 62). However, in R. meliloti, O-antigen is not required for nodule formation (63), possibly because the exo-polysaccharides of R. meliloti (64) can substitute for O-antigen.
Whether or not lipid A plays an important role in symbiosis of R. etli and leguminosarum with plants remains to be determined. It is conceivable (although not proven) that some kinds of lipid A molecules may activate the innate immune system of plants, as happens in animal systems (65). To address the role of lipid A during symbiosis, a structure-function study would be very informative. Well defined mutations in the lipid A biosynthetic pathway are needed for this purpose. Construction of the relevant mutants relies on an in-depth understanding of the molecular genetics of lipid A biosynthesis, which in turn, requires that the covalent structure of lipid A is known.
In this context, Carlson and co-workers (33, 34) have reported a most remarkable structure for the lipid A of R. etli when contrasted with the lipid A species found in other Gram-negative bacteria (Fig. 1). Their structure was based largely on the composition of the fatty acids and sugars released from R. etli CE3 lipid A that had been subjected to strong acid or alkaline hydrolyses (33, 34). Our new methods for the isolation and purification of intact lipid A components of R. etli have allowed us to identify the multiple but closely related components that make up this material. Our results confirm all the unusual compositional features of R. etli lipid A described by Carlson and co-workers (33, 34), including the presence of the galacturonic acid, the 27-hydroxyoctacosanoate, and the aminogluconate moieties (Fig. 1). However, our results differ from theirs in that we find extensive microheterogeneity in the proximal unit in conjunction with a conserved distal unit that contains an unusual acyloxyacyl group (Fig. 10).
As shown in the accompanying article (73), our structural findings have allowed us to demonstrate that the component with the conventional glucosamine disaccharide (B) is the precursor of the aminogluconate-containing component D-1. This scenario is consistent with our previous observation that R. etli has the capacity to synthesize the E. coli lipid A precursor Kdo2-lipid IVA (Fig. 2) (39), which is then further modified in a unique manner. C and E are likely to be derived from B and D-1, respectively. A membrane-associated deacylase from R. etli has recently been shown to hydrolyze the ester-linked fatty acid at the C-3 position of the precursors, lipid IVA and Kdo2-lipid IVA (66), which would account for the observed 3-O-deacylated lipid A components C and E isolated from cells (Fig. 10). NMR spectra of the purified samples, discussed in the accompanying paper (73), strongly support the conclusion that B and D-1 are indeed acylated at position 3, whereas C and E are not. However, the isomer D-2 arises by ester-linked acyl chain migration on the proximal unit of D-1 (73).
Although the purified components migrate as single bands during TLC in
two solvent systems (Fig. 4), the MALDI/TOF mass spectra display peaks
corresponding to additional subspecies with or without the
-hydroxybutyryl moiety (Figs. 5, 6, and 10). This appendage is
likely attached to the 27-OH of the 27-hydroxyoctacosanoic acid residue
(34). We believe that acylation of the 27-OH group with
-hydroxybutyrate occurs after acyloxyacyl group formation during
lipid A biosynthesis, because the C28-AcpXL acyl donor substrate,
previously reported by our laboratory, is not substituted with a
-hydroxybutyryl group (42).
The fatty acids shown in the proposed structures (Fig. 10) reflect the major ones observed in our own GC/MS analyses (Fig. 9) and are consistent with those reported by Bhat et al. (33). A small amount of C15 (Fig. 9) may be attached at position 3 of the proximal unit, because its presence (33) would account for some of the minor peaks in the spectra of B, D-1, and D-2 (Figs. 5 and 6), differing from the major molecular ions by 14 atomic mass units. As shown in Fig. 10, the proximal sugar unit is further proposed to vary with respect to the lengths of the N-linked fatty acyl chains at the C-2 position, whereas the C-2' position is substituted predominantly with hydroxymyristate. This conclusion is based on the masses of the B1+ ions of each of the components (Fig. 6) and the compositional analyses of Carlson and co-workers (33), who noted the same asymmetry in the distribution of the N-linked acyl chains at 2 and 2'.
The distribution of the N-linked hydroxyacyl chains has subtle implications for the biosynthesis of lipid A in R. etli. One possibility is that LpxD (the N-acyltransferase) (6, 16) and LpxB (the disaccharide synthase) (6, 16) of R. etli have different acyl chain length specificity than their E. coli counterparts. For instance, the N-acyltransferase of R. etli might be able to function with 14-, 16-, and 18-carbon hydroxyacyl-ACP substrates, generating a family of UDP-2,3-diacylglucosamine species differing in the lengths of their N-linked acyl chains. If R. etli LpxB displayed an absolute specificity for UDP-2,3-bis-(R-3-hydroxymyristoyl)-glucosamine as the donor but preferred longer N-acyl chain lengths in the 2,3-diacylglucosamine-phosphate acceptor, the observed asymmetry in N-acyl chain lengths (Fig. 10) would be generated.
The available partial sequence of the R. meliloti genome shows that all the key enzymes of lipid A biosynthesis that generate the intermediate Kdo2-lipid IVA (Fig. 2), initially discovered in E. coli (1, 6, 16), are also present in R. meliloti and are probably encoded by single genes, as in other systems. These observations are consistent with previous enzymatic studies of R. leguminosarum and etli cell extracts (39), in which efficient synthesis of Kdo2-lipid IVA from UDP-N-acetylglucosamine was observed (Fig. 2). However, R. leguminosarum and R. etli also possess unique enzymes (Fig. 2) that incorporate the C28 chain (42) and dephosphorylate the 1 (41) and 4' positions (40, 67). A membrane-associated in vitro system for the conversion of component B to D-1, presumably reflecting the oxidation of the proximal glucosamine of B to aminogluconate, is described in the accompanying article (73). The identification of this interesting reaction would not have been possible without the analytical techniques described above. Ultimately, the cloning and targeted inactivation of the C28 acyltransferase, the 1 and 4' phosphatases, and the putative glucosamine oxidase (dehydrogenase) will be necessary to alter the structure of R. etli lipid A in living cells and to asses their roles during plant symbiosis. R. meliloti membranes do not contain the phosphatases and do not oxidize the proximal lipid A unit, but they do have long chain acyltransferase activity,2 consistent with the presence of long acyl chains in all Rhizobiaceae (35).
Now that the R. etli lipid A components are available in a
highly purified state, their biological and immunostimulatory
properties can be studied. Because the fatty acid compositions of other
lipid A species have been demonstrated to be important determinants of
mammalian immune responses (68-72), one might predict that the C28-containing lipid A species found in R. etli and
Rhizobiaceae might also have unusual properties. Of further
interest are the roles played by the negative charges imparted by the
4'-galacturonic acid (Fig. 10) and the proximal aminogluconate
moieties. The unusual lipid A components of R. etli may
contribute to a clearer understanding of structure-activity
relationships in the elicitation of innate immunity and in the
establishment of symbiosis between plants and bacteria.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Amina S. Woods for assistance with MALDI/TOF experiments and Sean Murray at the University of Minnesota Mass Spectrometry Laboratory for help with the GC/MS experiments. We thank Dr. Gary Gray and Dr. Serena Farquharson for helpful discussions of the GC/MS data.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants R37-GM-51796 (to C. R. H. R.) and GM-54882 (to R. J. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Biochemistry, Duke University Medical Center, Box 3711, Durham, NC 27710. Tel.: 919-684-5326; Fax: 919-684-8885; E-mail: raetz@biochem.duke.edu.
Published, JBC Papers in Press, June 15, 2000, DOI 10.1074/jbc.M004008200
2 S. Basu and C. R. H. Raetz, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: LPS, lipopolysaccharide; Kdo, 3-deoxy-D-manno-octulosonic acid; MALDI/TOF, matrix-assisted laser desorption ionization/time of flight; GC/MS, gas chromatography/mass spectrometry.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Raetz, C. R. H. (1990) Annu. Rev. Biochem. 59, 129-170 |
| 2. | Raetz, C. R. H. (1993) J. Bacteriol. 175, 5745-5753 |
| 3. | Schnaitman, C. A., and Klena, J. D. (1993) Microbiol. Rev. 57, 655-682 |
| 4. | Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., Schreier, M., and Brade, H. (1994) FASEB J. 8, 217-225 |
| 5. | Whitfield, C. (1995) Trends Microbiol. 3, 178-185 |
| 6. | Raetz, C. R. H. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed), 2nd Ed., Vol. 1 , pp. 1035-1063, American Society for Microbiology, Washington, D.C. |
| 7. | Reeves, P. R., Hobbs, M., Valvano, M. A., Skurnik, M., Whitfield, C., Coplin, D., Kido, N., Klena, J., Maskell, D., Raetz, C. R. H., and Rick, P. D. (1996) Trends Microbiol. 4, 495-503 |
| 8. | Vaara, M. (1993) Antimicrob. Agents Chemother. 37, 2255-2260 |
| 9. | Nikaido, H. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed), 2nd Ed., Vol. 1 , pp. 29-47, American Society for Microbiology, Washington, D.C. |
| 10. | Galloway, S. M., and Raetz, C. R. H. (1990) J. Biol. Chem. 265, 6394-6402 |
| 11. | Kelly, T. M., Stachula, S. A., Raetz, C. R. H., and Anderson, M. S. (1993) J. Biol. Chem. 268, 19866-19874 |
| 12. | Onishi, H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M. H., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., and Raetz, C. R. H. (1996) Science 274, 980-982 |
| 13. | Garrett, T. A., Que, N. L., and Raetz, C. R. H. (1998) J. Biol. Chem. 273, 12457-12465 |
| 14. | Belunis, C. J., Clementz, T., Carty, S. M., and Raetz, C. R. H. (1995) J. Biol. Chem. 270, 27646-27652 |
| 15. | Ulevitch, R. J., and Tobias, P. S. (1995) Annu. Rev. Immunol. 13, 437-457 |
| 16. | Wyckoff, T. J. O., Raetz, C. R. H., and Jackman, J. E. (1998) Trends Microbiol. 6, 154-159 |
| 17. | Morrison, D. C., Vogel, S., Opal, S., and Brade, H. (1999) Endotoxin in Health and Disease , Marcel Dekker, NY |
| 18. | Karow, M., and Georgopoulos, C. (1992) J. Bacteriol. 174, 702-710 |
| 19. | Clementz, T., Bednarski, J., and Raetz, C. R. H. (1995) FASEB J. 9, 1311 (abstr.) |
| 20. | Clementz, T., Zhou, Z., and Raetz, C. R. H. (1997) J. Biol. Chem. 272, 10353-10360 |
| 21. | Somerville Jr, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., and Darveau, R. P. (1996) J. Clin. Invest. 97, 359-365 |
| 22. | Khan, S. A., Everest, P., Servos, S., Foxwell, N., Zahringer, U., Brade, H., Rietschel, E. T., Dougan, G., Charles, I. G., and Maskell, D. J. (1998) Mol. Microbiol. 29, 571-579 |
| 23. | Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S. L., Luo, X., Miller, S. I., Zheng, L., King, I., Pawelek, J. M., and Bermudes, D. (1999) Nat. Biotechnol. 17, 37-41 |
| 24. | Raetz, C. R. H., Takayama, K., Anderson, L., Armitage, I. M., and Strain, S. M. (1984) Fed. Proc. 43, 1567 |
| 25. | Raetz, C. R. H., Purcell, S., Meyer, M. V., Qureshi, N., and Takayama, K. (1985) J. Biol. Chem. 260, 16080-16088 |
| 26. | Strain, S. M., Armitage, I. M., Anderson, L., Takayama, K., Qureshi, N., and Raetz, C. R. H. (1985) J. Biol. Chem. 260, 16089-16098 |
| 27. | Rietschel, E. T., Brade, L., Lindner, B., and Zähringer, U. (1992) in Bacterial Endotoxic Lipopolysaccharides: Molecular Biochemistry and Cellular Biology (Morrison, D. C. , and Ryan, J. L., eds), Vol. I , pp. 3-41, CRC Press, Boca Raton, FL |
| 28. | Nummila, K., Kilpelainen, I., Zähringer, U., Vaara, M., and Helander, I. M. (1995) Mol. Microbiol. 16, 271-278 |
| 29. | Zhou, Z., Lin, S., Cotter, R. J., and Raetz, C. R. (1999) J. Biol. Chem. 274, 18503-18514 |
| 30. | Guo, L., Lim, K. B., Gunn, J. S., Bainbridge, B., Darveau, R. P., Hackett, M., and Miller, S. I. (1997) Science 276, 250-253 |
| 31. | Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., and Miller, S. I. (1998) Mol. Microbiol. 27, 1171-1182 |
| 32. | Ernst, R. K., Guina, T., and Miller, S. I. (1999) J. Infect. Dis. 179 (Suppl. 2), S326-S330 |